Patent ID: 11912660
Assignee: XAVIER UNIVERSITY OF LOUISIANA
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A compound according to formula (IIa) or formula (IIb), a stereoisomer, pharmaceutically acceptable salt and/or solvate thereof:, wherein
R is H;
X is —NH2;
R1 is NR5COR5;
R2 and R3 are each independently selected from the group consisting of H and NR5COR5;
R4 is selected from the group consisting of H, halogen, C1-6 alkyl, C1-6 alkenyl, C1-6 alkoxy, C1-6 haloalkyl, haloC1-6 alkoxy, —COOH, —CONH2, —COC1-6 alkyl, O—C1-6 alkyl, NH—C1-6 alkyl, —S C1-6 alkyl groups, —CN, —NH2, and —NO2; and
R5 is selected form the group consisting of H, aryl, C3-8 cycloalkyl, monocyclic or bicyclic heterocyclyl, and monocyclic or bicyclic heteroaryl, wherein the aryl, heteroaryl or heterocyclyl groups may be optionally substituted by one or more R4 groups.